维普中文期刊产品整合服务
40篇 您的检索式:作者名="Hyder J"
    题名 作者 年代 出处 被引量
1PPARγ-dependent peptidoglycan recognition protein 3 (PGlyRP3) expression regulates proinflammatory cytokines by microbial and dietary fatty acids显示文摘Marwa Zenhom Ayman Hyder Ina Kraus-Stojanowic Annegret Auinger Thomas Roeder Jürgen Schrezenmeir 2010Immunobiology2010,,6:1
2Optimization of location and size of opening in a pressure vessel cylinder using ANSYS显示文摘Hyder M J Asif M 2008Engineering Failure Analysis2008,15,12:1
3Estrogen regulation of throm- bospondin-1 in human breast cancer cells 显示文摘Hyder SM Liang Y Wu J 2009Int J Cancer2009,125,:1
4Regulation d thrtmixspondin-1 by natural and synthetic progestins in human breast cancer cells 显示文摘Hyder SM Liang Y Wu J 2009Endocr Relat Cancer2009,16,:1
5Regulation of vascular endothelial growth factor exprssion by estrogen and prosgestogens显示文摘HYDER S M HUANG J C NAWAZ Z 2000Environ Health Perspect2000,108,5:1
6Regulation of vascular endothelial growth factor expression by estrogens and progestins显示文摘HYDER S M HUANG J C NAWAZ Z 2000Environ Health Perspect2000,108,5:1
7Regulation of vascular endothelial growth factor expression by estrogens and progesterones显示文摘HYDER S M HUANG J C 2000Environ Health Perspect2000,108,10:1
8TREM-1 as apotential therapeutic target in psoriasis显示文摘HYDER LA GONZALEZ J HARDEN JL 2013J Invest Dermatol2013,133,7:1
9Treated Kaolin Combines Effective Pitch Control with Handling Ease显示文摘Carter A R D Hyder J 1993Pulp & Paper1993,67,11:1
10Regulation of vascular endothelial growth factor expression by estrongens and progestins显示文摘Hyder S M Huang J C Nawaz Z 2000Environ Health Perspect2000,,:1
11Regulation of vascular endothelial growth factor expression by estrogens and progestins显示文摘Hyder S M Huang J C Nawaz Z 2000Environ Health Perspect2000,108,5:1
12Acute fulminant fungal sinusitis:clinical presentation,radiological findinga and treatment显示文摘Sohail MA Al Khabori M Hyder J 0,,:1
13Ligand-and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells显示文摘Wu J Brandt S Hyder SM 2005Mol Endocrinol2005,19,2:1
14Oxygen profile of microencapsulated islets: effect of immobilized hemoglobin in the alginate matrix 显示文摘Schrezenmeir J Hyder A Vreden M 2001Transplant Proc2001,33,:1
15Slug tests in unconfined formations: anassessment of the Bouwer and Rice technique显示文摘HYDER Z BUTLER JR J J 1995Groundwater1995,33,1:1
16Regulation of vascular endothelial growth factor expression by estrogens and progestins 显示文摘Hyder S M Huang J C Nawaz Z 2000Environ Health Perspect2000,108,5:1
17Estimation of pasture growth rate in the south west of Western Australia from AVHRR NDVI and climate data显示文摘Hill M J Donald G E Hyder M W 0,,:1
18Acute fulmi- nant fungal sinusitis: clinical presentation, radiological findings and treatment显示文摘Sohail MA Al Khabori M Hyder J 2001Acta Trop2001,80,2:1
19Characterization of gut microbiome and metabolome in Helicobacter pylori patients in an underprivileged community in the United States显示文摘BACKGROUND Helicobacter pylori(H.pylori),a bacterium that infects approximately half of the world’s population,is associated with various gastrointestinal diseases,including peptic ulcers,non-ulcer dyspepsia,gastric adenocarcinoma,and gastric lymphoma.As the burden of antibiotic resistance increases,the need for new adjunct therapies designed to facilitate H.pylori eradication and reduce negative distal outcomes associated with infection has become more pressing.Characterization of the interactions between H.pylori,the fecal microbiome,and fecal fatty acid metabolism,as well as the mechanisms underlying these interactions,may offer new therapeutic approaches.AIM To characterize the gut microbiome and metabolome in H.pylori patients in a socioeconomically challenged and underprivileged inner-city community.METHODS Stool samples from 19 H.pylori patients and 16 control subjects were analyzed.16S rRNA gene sequencing was performed on normalized pooled amplicons using the Illumina MiSeq System using a MiSeq reagent kit v2.Alpha and beta diversity analyses were performed in QIIME 2.Non-targeted fatty acid analysis of the samples was carried out using gas chromatography-mass spectrometry,which measures the total content of 30 fatty acids in stool after conversion into their corresponding fatty acid methyl esters.Multi-dimensional scaling(MDS)was performed on Bray-Curtis distance matrices created from both the metabolomics and microbiome datasets and a Procrustes test was performed on the metabolomics and microbiome MDS coordinates.RESULTS Fecal microbiome analysis showed that alpha diversity was lowest in H.pylori patients over 40 years of age compared to control subjects of similar age group.Beta diversity analysis of the samples revealed significant differences in microbial community structure between H.pylori patients and control subjects across all ages.Thirty-eight and six taxa had lower and higher relative abundance in H.pylori patients,respectively.Taxa that were enriched in H.pylori patients included Atopobium,Gemellaceae,Micrococcaceae,Gemellales and Rothia(R.mucilaginosa).Notably,relative abundance of the phylum Verrucomicrobia was decreased in H.pylori patients compared to control subjects.Procrustes analysis showed a significant relationship between the microbiome and metabolome datasets.Stool samples from H.pylori patients showed increases in several fatty acids including the polyunsaturated fatty acids(PUFAs)22:4n6,22:5n3,20:3n6 and 22:2n6,while decreases were noted in other fatty acids including the PUFA 18:3n6.The pattern of changes in fatty acid concentration correlated to the Bacteroidetes:Firmicutes ratio determined by 16S rRNA gene analysis.CONCLUSION This exploratory study demonstrates H.pylori-associated changes to the fecal microbiome and fecal fatty acid metabolism.Such changes may have implications for improving eradication rates and minimizing associated negative distal outcomes.Brian White John D Sterrett Zoya Grigoryan Lauren Lally Jared D Heinze Hyder Alikhan Christopher A Lowry Lark J Perez Joshua DeSipio Sangita Phadtare 2021World Journal of Gastroenterology2021,27,33:1
20TREM-1 as a potential therapeutic target in psoriasis 显示文摘Hyder LA Gonzalez J Harden JL 2013J Invest Dermatol2013,133,7:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费